Highlights
NYSE: ACT       Advisorshares Vice ETF
Last Price Today's Change   Day's Range   Trading Volume
0.00   0.00 (0.00%)  0.00 - 0.00  0

Overview

 
Avg Volume (4 weeks):0
52 Weeks Range:16.16 - 28.16
52 Weeks Price Volatility (%):
0.00%
Average Price Target: 340.00
Price Target Upside/Downside: +340.00

Headlines



No recent Headlines for this stock.


Business Background

Actavis plc is a global, integrated specialty pharmaceutical company. The Company focused on developing, manufacturing and distributing generic, brand and biosimilar products. The Company produces and markets generic, branded generic, branded and over-the-counter (OTC) pharmaceutical products covering all therapeutic classes. The Company's product formulations include modified release, solid oral dosage, semi-solids, suspensions, transdermals, suppositories, creams, ointments, liquids and injectables. In October 2013, Actavis Inc acquired Warner Chilcott PLC and in connection with the acquisition, Actavis Inc and Warner Chilcott PLC have been combined under a new company, Actavis plc.

  Be the first to like this.
 


APPS
I3 Messenger
Individual or Group chat with anyone on I3investor
 
 

6239  2800  512  101 

ActiveGainersLosers
Top 10 Active Counters
 NameLastChange 
 AMC 3.51+0.60 
 CTRM 0.405-0.008 
 ADMP 1.79-0.54 
 GME 65.01+22.42 
 SNDL 0.645+0.003 
 AZRX 1.84+0.62 
 PLTR 32.58+6.73 
 SENS 2.31+0.08 
 MKD 1.53+0.64 
 NIO 61.95+3.00